It has been suggested previously that fructose promotes the growth of some tumors directly—by serving as a fuel. Now, new ...

Phase one of Samabriva’s new facility in Liege, Belgium, is expected to be operational in the first quarter in 2025.

HILIC-MS lets free thiols in mAb processing be localized directly and quantified at domain-specific resolution.

Scientists used transcriptomics to analyze the HCPs, especially the problematic ones, in CHO cultures, and looked for an ...

Large datasets can be used by machine learning to make predictions for better choice of culture media conditions.

Nanoscopy technology can drive biological discovery not just with imagery, but also with meaningful quantitative data.

New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.

Researchers have developed a new organoid that mimics the human fetal pancreas, offering a clearer view of its early development.

Delivering biologics via oral administration represents a growing market that is expected to exhibit 35% CAGR from 2023–2028.

Prostate cancer and other cancers characterized by “cold” tumors could become more responsive to checkpoint blockade if UBA1 is inhibited.

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

As 2024 comes to a close, it is the perfect time to reflect on the science and industry news from the past year. And it’s ...